FAQs | STAR Immunotherapy Study
- About Us
-
Cancer Care
-
Our Cancer Programs
- Adolescent and Young Adult Cancer Program
- Blood Cancer & Hematological Malignancy Program
- Blood Disorder (Hematology) Program
- Breast Cancer Program
- Cancer Risk Reduction and Education Clinic
- Cardio-Oncology Program
- Cancer Genetics Program
- Childhood Cancer Survivorship Program
- Endocrine Tumor Program
- Eye Cancer Program
- Gastrointestinal (GI) Cancer Program
- Genitourinary Cancer Program
- Gynecologic Oncology Program
- Head and Neck Cancer Program
- Liver Tumor and Cancer Program
- Lung Cancer Program
- Neuro-Oncology (Brain Tumor) Program
- Neurofibromatosis Program
- Pediatric Neuro-Oncology Program
- Pediatric Oncology Program
- Pediatric Sarcoma Program
- Pediatric Thrombosis Program
- Radiation Oncology
- Sarcoma Cancer Program
- Skin Cancer Program
- Supportive Cancer Care Program
-
Screening and Diagnosis
- Cervical Cancer Screening Guidelines
- Colorectal Cancer Screening
- Endometrial (Uterine) Cancer Screening Guidelines
- Hepatitis and Cancer
- HPV Vaccine and Screenings
- Liver Cancer Guidelines
- Lung Cancer Screening
- Mammogram
- Ovarian Cancer Screening Guidelines
- Prostate Cancer Screening Guidelines
- Skin Cancer Screenings
- Sun and Skin Safety
- Tobacco Use and Cancer
- Skin Cancer Screenings
- Cancer Genetics Program
- Cancer Survivorship Program
- Cancer Treatments
- Conditions
-
Our Cancer Programs
- Clinical Trials and Research
- Donate and Volunteer
- Education
- Patients and Families
- Appointments
- Doctors and Locations
-
Community Outreach and Engagement Program
- Message from COE Leadership
- South Texas Cancer Burden and COE Areas of Work
- Our COE Impact
- COE Community Advisory Board
- COE Publications
- Avanzando Caminos (Leading Pathways) Study
- Estudio Avanzando Caminos (Leading Pathways)
- San Antonio Firefighters Cancer Prevention Program
- STAR Immunotherapy Study
What is STAR
STAR stands for Symptomatic Toxicities Assessment and Reporting, a system that helps us better understand the side effects you may experience during immunotherapy. It allows us to ask how you’re feeling — including symptoms like tiredness, pain, nausea, skin changes, stomach problems, or mood changes — and to track these symptoms over time, noting when they start, how long they last, and how much they affect your daily life so we can get a complete picture of your health during treatment.
Why This Study Matters
- Little information has been captured patient's experiences on checkpoint inhibitors using patient reported outcomes
- Existing tools do not address many symptomatic toxicities that are related to checkpoint inhibitors.